written on 07.03.2014

EU suggests new warning for same sleeping pill that landed a Kennedy before a jury

TAGS: ,

Sleep drugs have been the root of plenty of safety worries over the years, especially when it comes to driving while under their influence. Now, just a week after the wrap of one of the highest-profile cases to revolve around Ambien generic zolpidem–Kerry Kennedy's–the European Medicines Agency's Pharmacovigilance Risk Assessment Committee is recommending updates to its product information to underscore the drug's associated risks.